Company Overview - Yirui Technology's closing price on July 11 was 88.55 yuan, down 1.01%, with a rolling PE ratio of 37.80 times and a total market value of 17.729 billion yuan [1] - The company ranks 77th in the medical device industry, which has an average PE ratio of 52.06 times and a median of 37.22 times [1] - As of the first quarter of 2025, 47 institutions held shares in Yirui Technology, including 39 funds, with a total holding of 82.5452 million shares valued at 9.443 billion yuan [1] Business Operations - Yirui Technology focuses on the research, production, sales, and service of digital X-ray detectors, high-voltage generators, combination ray sources, and tubes [1] - The main product lines include the universal series, dental series, mammography series, radiotherapy series, industrial series, high-voltage generators, and combination ray sources [1] Financial Performance - In the first quarter of 2025, Yirui Technology reported revenue of 482 million yuan, a year-on-year decrease of 1.92%, while net profit was 143 million yuan, an increase of 2.74% [1] - The sales gross margin for the company was 48.92% [1]

Group 1 - The core viewpoint of the news is that Yirui Technology's stock performance and financial metrics indicate a stable position within the medical device industry, despite a slight decline in revenue [1] - As of July 1, Yirui Technology's closing price was 88.5 yuan, with a PE ratio of 37.78 times and a total market capitalization of 17.719 billion yuan [1] - The average PE ratio for the medical device industry is 51.70 times, with a median of 37.36 times, positioning Yirui Technology at the 77th rank within the industry [1][2] Group 2 - Yirui Technology reported a revenue of 482 million yuan for Q1 2025, reflecting a year-on-year decrease of 1.92%, while net profit was 143 million yuan, showing a year-on-year increase of 2.74% [1] - The company's gross profit margin stands at 48.92% [1] - As of March 31, 2025, Yirui Technology had 5,745 shareholders, a decrease of 883 from the previous count, with an average holding value of 352,800 yuan per shareholder [1]

Group 1 - The core viewpoint of the news is that Yirui Technology's stock performance and financial metrics indicate a competitive position within the medical device industry, despite a slight decline in stock price and revenue [1] - As of June 26, Yirui Technology's closing price was 88.77 yuan, down 1.31%, with a rolling PE ratio of 37.90 times and a total market capitalization of 17.773 billion yuan [1] - The average PE ratio for the medical device industry is 49.45 times, with a median of 35.92 times, positioning Yirui Technology at the 80th rank within the industry [1][2] Group 2 - As of March 31, 2025, Yirui Technology had 5,745 shareholders, a decrease of 883 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] - The main business of Yirui Technology includes the research, production, sales, and service of digital X-ray detectors, high-voltage generators, and other core components [1] - In the latest quarterly report for Q1 2025, Yirui Technology reported an operating income of 482 million yuan, a year-on-year decrease of 1.92%, and a net profit of 143 million yuan, a year-on-year increase of 2.74%, with a gross profit margin of 48.92% [1]

分业务看：2024 年探测器业务实现营收14.90 亿元，同比-11.99%；解决方案/技术服务收入实现营收 0.96 亿元，同比+262.56%；核心部件销售实现营收1.26 亿元，同比+45.49%。 毛利率短期承压，持续加大研发投入 毛利率：2024 年公司毛利率为50.11%，同比-7.73%，25Q1 年公司毛利率为48.92%，同比-4.41pct，环 比+10.71pct。我们认为毛利率大幅下滑主要系产品结构变化所致。 事件概述 奕瑞科技发布2024 年及2025 年一季报。 2024 年实现营业收入18.31 亿元，同比-1.74%；归母净利润4.65 亿元，同比-23.43%；扣非归母净利润 4.39 亿元，同比-25.84%。 25Q1 实现营业收入4.82 亿元，同比-1.92%，环比+1.32%；归母净利润1.43 亿元，同比+2.74%，环比 +90.72%；扣非归母净利润1.41 亿元，同比-9.19%，环比+167.05%。 业绩符合市场预期 打造数字化X 射线核心部件及综合解决方案供应商 探测器： 2024 年，公司成功推出多款医疗和工业新产品，高端 DSA 探测器进入量产阶段 ...